Pain medication use in youth athletes: a cross‐sectional study of 466 youth handball players

Author(s):  
Dilara Merve Sari ◽  
Julie Rønne Pedersen ◽  
Jonas Bloch Thorlund ◽  
Ulla Ramer Mikkelsen ◽  
Merete Møller
2014 ◽  
Vol 17;1 (1;17) ◽  
pp. 81-94 ◽  
Author(s):  
Andreas Schwarzer

Background: Despite hints about the high incidence of pain patients misreporting their pain medication use, there are only a few non-controlled studies on the topic that focus solely on opioids. Objective: Using toxicological analyses in a cross-sectional study, we investigated patients’ reliability regarding their report of any current pain medication use. Study Design: A cross-sectional study. Setting: A comprehensive pain center and a surgical unit of a German University Hospital. Methods: Consecutive outpatients at their first visit to the pain clinic (PG, n = 243) and pre-surgical control patients (SG, n = 100) suffering from pain reported on their current pain medication. The patients’ reports were verified in serum and urine using specific toxicological methods. Two types of noncompliance were defined: under-reporting (detection of non-reported substances) and overreporting (reported substances undetectable). The impact of clinical parameters on compliance was investigated using binary logistic regression. Results: The incidence of noncompliance was significantly higher in the PG (43.3%) than in the SG (24%; P < 0.05). Under-reporting occurred similarly in both groups (31% PG; 23% SG), whereas over-reporting predominantly appeared in the PG (11% vs. 2%; P < 0.05). Opioids were not most frequently under-reported, but the highest proportion of under-reported drugs (underreported in relation to detection incidence) was found for non-opioid analgesics (NSAIDs: 29% PG; 25% SG; other: 42% PG; 32% SG) and psychotropic drugs (35% PG; 53% SG). In the PG, logistic regression revealed high depression scores to be predictive for noncompliance (odds ratio 2.12). Limitations: Due to lack of a structured follow-up interview motives of under- and over-reporting stay speculative. Conclusions: Under-reporting of non-opioid analgesics is the main type of noncompliance, a disquieting fact in light of their toxicity and adverse effects. Further research is required in terms of drug assessment and compliance improvement strategies in pain clinics; therefore, toxicological monitoring is indispensable. Clinical Trial: NCT01625065; Medi-3889-10 Key words: Medication compliance, adherence, chronic pain, toxicological analyses, urine drug testing, NSAID, opioids


2020 ◽  
Vol 7 ◽  
pp. 2333794X2098134
Author(s):  
Henry Clark ◽  
Delesha Carpenter ◽  
Kathleen Walsh ◽  
Scott A. Davis ◽  
Nacire Garcia ◽  
...  

The purpose of this study was to describe the number and types of errors that adolescents and caregivers report making when using asthma controller medications. A total of 319 adolescents ages 11 to 17 with persistent asthma and their caregivers participated in this cross-sectional study. Adolescent and caregiver reports of asthma medication use were compared to the prescribed directions in the medical record. An error was defined as discrepancies between reported use and the prescribed directions. About 38% of adolescents reported 1 error in using asthma controller medications, 16% reported 2 errors, and 5% reported 3 or more errors. About 42% of caregivers reported 1 error in adolescents using asthma controller medications, 14% reported 2 errors, while 6% reported 3 or more errors. The type of error most frequently reported by both was not taking the medication at all. Providers should ask open-ended questions of adolescents with asthma during visits so they can detect and educate families on how to overcome errors in taking controller medication use.


2009 ◽  
Vol 9 (1) ◽  
Author(s):  
Eva Mann ◽  
Sascha Köpke ◽  
Burkhard Haastert ◽  
Kaisu Pitkälä ◽  
Gabriele Meyer

2013 ◽  
Vol 27 (1) ◽  
pp. 61-64
Author(s):  
Robert D. Beckett ◽  
Marina Yazdi ◽  
Laura J. Hanson ◽  
Ross W. Thompson

Purpose: Describe medication safety metrics used at University HealthSystem Consortium (UHC) institutions and recommend a meaningful way to report and communicate medication safety information across an organization. Methods: A cross-sectional study was conducted using an electronically distributed, open-ended survey instrument. Results: Twenty percent of the UHC institutions responded to our survey. Seventy-seven percent of those institutions responding to our survey reported their organization has defined metrics to measure medication safety; an additional 21% of the institutions were still in the process of defining metrics. Of metrics that were reported, 33% were true medication safety metrics. Results are distributed to a wide variety of institutional venues. Conclusion: Institutions should take several actions related to medication safety including defining local metrics; building metrics addressing preventable adverse drug events, medication errors, and technology; and reporting results to a variety of venues in order to design specific interventions to improve local medication use.


Author(s):  
Paulo Celso Prado Telles Filho ◽  
Tatiana Longo Borges ◽  
Assis do Carmo Pereira ◽  
Kelly Graziani Giacchero Vedana ◽  
Rebecca O. Shasanmi ◽  
...  

Pain Medicine ◽  
2020 ◽  
Vol 21 (11) ◽  
pp. 3205-3214
Author(s):  
Jean-Luc Kaboré ◽  
Lise Dassieu ◽  
Élise Roy ◽  
Didier Jutras-Aswad ◽  
Julie Bruneau ◽  
...  

Abstract Introduction Most studies on chronic noncancer pain (CNCP) in people who use drugs (PWUD) are restricted to people attending substance use disorder treatment programs. This study assessed the prevalence of CNCP in a community-based sample of PWUD, identified factors associated with pain, and documented strategies used for pain relief. Methods This was a cross-sectional study nested in an ongoing cohort of PWUD in Montreal, Canada. Questionnaires were administered to PWUD seen between February 2017 and January 2018. CNCP was defined as pain lasting three or more months and not associated with cancer. Results A total of 417 PWUD were included (mean age = 44.6 ± 10.6 years, 84% men). The prevalence of CNCP was 44.8%, and the median pain duration (interquartile range) was 12 (5–18) years. The presence of CNCP was associated with older age (&gt;45 years old; odds ratio [OR] = 1.8, 95% CI = 1.2–2.7), male sex (OR = 2.3, 95% CI = 1.2–4.2), poor health condition (OR = 1.9, 95% CI = 1.3–3.0), moderate to severe psychological distress (OR = 2.9, 95% CI = 1.8–4.7), and less frequent cocaine use (OR = 0.5, 95% CI = 0.3–0.9). Among CNCP participants, 20.3% used pain medication from other people, whereas 22.5% used alcohol, cannabis, or illicit drugs to relieve pain. Among those who asked for pain medication (N = 24), 29.2% faced a refusal from the doctor. Conclusions CNCP was common among PWUD, and a good proportion of them used substances other than prescribed pain medication to relieve pain. Close collaboration of pain and addiction specialists as well as better pain assessment and access to nonpharmacological treatments could improve pain management in PWUD.


PLoS ONE ◽  
2020 ◽  
Vol 15 (2) ◽  
pp. e0229229 ◽  
Author(s):  
Juliana Schneider ◽  
Engi Algharably ◽  
Andrea Budnick ◽  
Arlett Wenzel ◽  
Dagmar Dräger ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document